South Korea’s Medipost acquires OmniaBio for contract development and manufacturing; Ottawa introduces legislation to bolster trust in the digital economy; a new oil sands alliance combines Canada’s three major oil producers, KPMG Canada and MaRS Discovery District launch a climate impact accelerator program, and more.
Topic: clinical trials
The Short Report – Oct. 20, 2021: A global research hub for vision care, a UWaterloo centre for sustainable aeronautics, the Writer’s Trust inaugural Balsillie prize, and more
A joint international research hub for vision health gets off the ground, UWaterloo launches its sustainable aeronautics research institute, Dan Breznitz and André Picard are shortlisted for the Balsillie Prize for Public Policy from the Writer’s Trust of Canada, and more.
The Short Report – May 26, 2021: Canada’s funding agencies launch interdisciplinary peer review program, Alberta launches medical studies website, and more
Canada’s three research funding agencies have launched the Tri-agency Interdisciplinary Peer Review Committee; Alberta creates a platform to boost clinical trials; Ontario Tech University is designated a collaboration centre by the UN International Atomic Energy Agency, and more.
Calgary vaccine developer reaches deal with Manitoba government after hearing no response from Ottawa
Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa’s “apathetic response” as “unacceptable” and he implored the government to take initiative to establish a secure domestic vaccine supply.
The Short Report, May 13, 2020: Public trust in science rising; new COVID-19 advisory councils created; OneEleven ceases operations; and more
COVID-19 NEWS Canadians’ trust in doctors, scientists and the government has increased since the cornovirus pandemic began, finds public opinion polls from January and repeated on May 1 and May 2. Conducted by Proof Strategies CanTrust Index of Ottawa, the survey found that 76% of Canadians trusted doctors and 70% trusted scientists. The follow up…
The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more
Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…
The Short Report, April 28, 2020: Alarming drop in donations for health charities; Health Canada approves COVID-19 clinical trial; and more
Health charities are seeing an “alarming” drop in donations, which they warn will compromise the health of Canadians living with chronic disease. HealthPartners, a collaboration of 16 Canadian charities, released the findings in its report, The Impact of COVID-19 on our Most Vulnerable Canadians. In response to declining donations, the report says health charities have…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...